Simpson Thacher advised New Mountain on the formation and raising of a $3.1 billion continuation vehicle to acquire portfolio company Real Chemistry from New Mountain Partners V — among the largest-ever single asset continuation vehicles raised to date.
New Mountain Capital is a leading growth-oriented alternative investment firm headquartered in New York. The firm currently manages private equity, strategic equity, credit and net lease real estate funds with approximately $55 billion in assets under management. Real Chemistry is a global health innovation company, focused on delivering analytics-driven, digital-first solutions to the healthcare industry.
The Simpson Thacher team included David Greene, Matthew Leighton, Nathan Calko, Joseph Teitelbaum, Maria Fernandez Garcia, Oluwatobi Olajubu, Xinyi Mao and Skyler Andrew Simon (Funds); Matthew Rogers and Michael Chen (M&A); and Andrew Purcell, Adam Hersch and Shareef Salfity (Tax).